The launch of Serbia’s first private health care platform
The private equity fund Blue Sea Capital has initiated the consolidation of some of the leading Serbian private health care providers, resulting in the creation of a unique health care platform under the brand name MediGroup. The private health care market in Serbia is still underdeveloped, and the respective management teams of Dr Ristic and Jevremova, supported by Blue Sea Capital, have formed MediGroup with the shared vision to become a nationwide provider of high quality health services across Serbia. At present Medigroup consists of health center Dr Ristic and special gynaecological hospital (with maternity ward), Jevremova, both long standing market leading institutions of excellent reputation. With the plan to build an extensive network of health centers both in Belgrade and in other major towns across Serbia, MediGroup aims to provide a range of comprehensive medical services to the population of Serbia, both in primary and secondary health care and to ensure easy access to necessary medical procedures using state of the art equipment and technology and offering access to top medical personnel.
Commenting on the establishment of the MediGroup platform, Sasa Galic, Managing Partner at Blue Sea Capital said: ”We are proud of the considerable development already achieved by the market-leading health care providers and existing members of the MediGroup platform, and are excited by the future growth prospects and reach of the brand we have created.”
For further information please contact:
Blue Sea Capital:
Sasa Galic / Vuk Vukovic
info@blueseacap.com
ABOUT BLUE SEA CAPITAL:
Blue Sea Capital is a regional private equity fund established in July 2011. It has offices in Belgrade and Zagreb.
The latest.
Blue Sea Capital completes sale of leading Croatian glass pharmaceutical packaging company to Japanese Nipro Corporation
Blue Sea Capital, a regional private equity fund, has successfully completed the sale of its 100 percent ownership stake in Piramida, a leading Croatian manufacturer of glass pharmaceutical packaging, to Nipro PharmaPackaging International NV, a subsidiary of Nipro Corporation which has its headquarters in Japan.…
European Investment Fund approves an investment in Blue Sea Capital Fund II
Blue Sea Capital is pleased to announce that the European Investment Fund (“EIF”) Board of Directors approved an investment in Blue Sea Capital Fund II, subject to satisfactory legal negotiations. EIF is expected to become an anchor investor in Blue Sea Capital Fund II…
Mid Europa and Blue Sea Capital complete Exit from Knjaz Miloš
Blue Sea Capital is pleased to announce that it has completed the sale of Knjaz Miloš, a major player in the production of mineral water and non-alcoholic beverages in Serbia and the surrounding region, to a joint venture between Karlovarské Minerální Vody and PepsiCo, Inc …
Mid Europa and Blue Sea Capital complete Exit from Bambi
Blue Sea Capital is pleased to announce that it has completed the sale of Bambi, the leading biscuit producer in countries of former Yugoslavia with its iconic Plazma brand, to Coca-Cola Hellenic Bottling Company …
KMV and PepsiCo Acquire Knjaz Miloš from Mid Europa and Blue Sea Capital
Blue Sea Capital is pleased to announce the signing of an agreement for sale of Knjaz Miloš, the leading producer of mineral water and non-alcoholic beverages in Serbia and the surrounding region, to a joint venture between Karlovarské Minerální Vody (“KMV”) and PepsiCo, Inc. (“PepsiCo”). The transaction is subject to customary competition authority clearance and is expected to close in Q3 2019 …